Neovascular Glaucoma

Neovascular glaucoma is a serious type of glaucoma that can develop when another eye disease causes new, abnormal blood vessels to grow in the eye's drainage angle. These new vessels can block the normal flow of fluid, increasing pressure inside the eye and potentially damaging the optic nerve, which can lead to vision loss.

Condition

What people with Neovascular Glaucoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Avastin (Bevacizumab) for Neovascular Glaucoma?

NameHow it went

About Neovascular Glaucoma

What It Is

Neovascular glaucoma is a serious form of glaucoma caused by abnormal new blood vessels growing on the iris (the colored part of the eye) and across the eye's drainage channels. Those vessels, and the scar-like tissue that comes with them, block the fluid that normally flows out of the front of the eye. Pressure inside the eye then rises, and that pressure damages the optic nerve, which carries vision from the eye to the brain. Unlike the common, slowly developing form of glaucoma, neovascular glaucoma is a secondary glaucoma: it always grows out of another eye or circulation problem. It is rare, but it can progress quickly. It often makes the eye red and painful, and without treatment it can cause permanent blindness. Catching it early, before the drainage angle is sealed off, gives the best chance of keeping useful vision.

Causes & Risk Factors

Almost every case starts with a retina that is not getting enough blood and oxygen. The starved retina releases a growth signal called VEGF (vascular endothelial growth factor), which prompts new blood vessels to form. Those vessels are fragile and leaky and grow in places they do not belong, including the iris and the drainage angle at the front of the eye. The three most common underlying causes are proliferative diabetic retinopathy (advanced diabetes damage to the retina), central retinal vein occlusion (a blockage of the main vein draining the retina) and ocular ischemic syndrome (poor blood flow to the eye, usually from narrowing of the carotid artery in the neck). After a major loss of blood flow to the retina, such as a vein occlusion, neovascular glaucoma usually appears within about 1.5 to 6 months. Less often it follows long-standing inflammation inside the eye, eye tumors, radiation or a chronic retinal detachment. Risk is higher in older adults and in people whose diabetes, blood pressure or cholesterol has been hard to control, because these conditions damage the small vessels that feed the retina.

How It's Diagnosed

An eye doctor, usually an ophthalmologist, looks at the iris with a slit lamp (a microscope with a bright beam of light) for the fine, irregular new vessels that mark this condition. Gonioscopy, in which a special contact lens is placed briefly on the numbed eye, lets the doctor see the drainage angle directly to check whether new vessels or scar tissue have begun to block or close it. Sometimes vessels appear in the angle before they are visible on the iris, so this step matters. Eye pressure is measured in millimeters of mercury (mmHg). The usual range is about 10 to 21. In neovascular glaucoma, pressure often climbs to 40 to 60 or higher once the angle is blocked. A dilated exam of the retina, and often imaging such as fluorescein angiography (photographs taken after a dye is injected into a vein) or optical coherence tomography angiography (a light-based scan that maps retinal blood flow), shows which parts of the retina are starved of blood. Because the eye problem reflects a problem elsewhere, the workup often includes checking blood sugar and HbA1c (a blood test of average blood sugar over about three months), blood pressure, and sometimes an ultrasound of the carotid arteries.

Treatment Options

Treatment works on two fronts at once: calming the new vessel growth by treating the starved retina, and lowering eye pressure to protect the optic nerve. Retina and glaucoma specialists often share the care. To treat the retina, the standard approach is panretinal photocoagulation, a laser treatment that places many small burns across the outer retina. This reduces the retina's oxygen demand so it releases less VEGF, and the new vessels gradually shrink. It does not restore vision that has already been lost. Anti-VEGF injections into the eye, such as bevacizumab (Avastin), ranibizumab (Lucentis) and aflibercept (Eylea), block the growth signal directly. These medicines are better known for treating wet macular degeneration and diabetic eye disease. They can make the new vessels regress within days and lower pressure in the short term, but the effect fades after roughly a month or so, and the evidence shows benefit only over the first several weeks. They are therefore used to buy time and reduce bleeding risk while laser or surgery takes effect, not as a treatment on their own. Pressure-lowering eye drops and sometimes pills help, and steroid and dilating drops can ease inflammation and pain. Drops are often not enough, however, and about half of affected eyes need a procedure. Options include a glaucoma drainage device (a small tube that carries fluid out of the eye), trabeculectomy (surgery that creates a new drainage path, usually with a medicine to limit scarring) and cyclophotocoagulation (a laser that reduces how much fluid the eye makes). The choice depends on how much vision remains and the state of the eye. When the eye has no useful vision, treatment focuses on comfort, and rarely, removing a blind, painful eye is the most effective relief. Managing the underlying condition, such as diabetes, blood pressure or carotid artery disease, is part of treatment and helps protect the other eye.

What to Expect

Neovascular glaucoma usually needs close follow-up, especially in the first weeks and months, with frequent visits to check pressure, repeat injections or laser, and decide whether surgery is needed. Many people go through more than one treatment before the pressure settles. The outlook depends heavily on how early treatment starts. When the new vessels are found before the drainage angle closes, treatment can often stop the process and preserve vision. Once the angle has sealed and pressure has stayed high, some vision loss is often permanent, and the aim shifts to keeping the remaining sight and keeping the eye comfortable. Vision is also limited by the retinal disease that caused the problem in the first place. Because the same underlying condition, such as diabetes or carotid disease, can affect both eyes, regular exams of the other eye are part of long-term care. If vision in one eye is lost, low-vision services can help with reading, driving decisions and moving around safely.

When to Seek Help

If you have proliferative diabetic retinopathy, a recent retinal vein occlusion or known carotid artery narrowing, keep the eye exam schedule your eye doctor sets, since early new vessels often cause no symptoms and are found only on examination. Arrange to be seen by an eye doctor the same day if an eye becomes red and aching, newly sensitive to light or blurrier than usual, particularly in the months after a retinal vein occlusion. Sudden, intense eye pain with blurred vision, especially with headache, nausea or vomiting, can mean eye pressure has risen sharply. Go to an eye care provider or an emergency room right away.

Questions to Ask Your Doctor

  1. 1.What stage is my neovascular glaucoma, and is the drainage angle still open?
  2. 2.What is causing the poor blood flow to my retina, and what needs to be done about that underlying condition?
  3. 3.How will laser, injections and surgery be combined in my case, and how will we know if they are working?
  4. 4.How much vision can realistically be preserved in this eye?
  5. 5.How often should my other eye be checked?

Last reviewed • Oct 2026

Educational content, not medical advice.